BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22763812)

  • 1. Repositioning of dexamethasone intravitreal implant (Ozurdex) migrated into the anterior chamber.
    Vela JI; Crespí J; Andreu D
    Int Ophthalmol; 2012 Dec; 32(6):583-4. PubMed ID: 22763812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).
    Kang H; Lee MW; Byeon SH; Koh HJ; Lee SC; Kim M
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1819-1825. PubMed ID: 28601910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.
    Khurana RN; Appa SN; McCannel CA; Elman MJ; Wittenberg SE; Parks DJ; Ahmad S; Yeh S
    Ophthalmology; 2014 Jan; 121(1):67-71. PubMed ID: 23890421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
    Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
    J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant.
    Stelton CR; Townsend J; Peterson LT; Khurana RN; Yeh S
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(7):756-9. PubMed ID: 26247457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases].
    Malclès A; Janin-Manificat H; Yhuel Y; Russo A; Agard E; El Chehab H; Ract Madoux G; Masse H; Burillon C; Dot C
    J Fr Ophtalmol; 2013 Apr; 36(4):362-7. PubMed ID: 23318000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anterior chamber dislocation of dexamethasone implant.
    Kishore SA; Schaal S
    Ocul Immunol Inflamm; 2013; 21(1):90-1. PubMed ID: 23323589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex).
    Ong J; Davidoss NH; Bhosale A; Balaratnasingam C
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior Chamber Migration of Ozurdex Implants.
    Kayıkcıoğlu Ö; Doğruya S; Sarıgül C; Mayalı H; Kurt E
    Turk J Ophthalmol; 2020 Apr; 50(2):115-122. PubMed ID: 32367704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple technique for management of anterior chamber-migrated Ozurdex
    Lee SH; Kang H; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
    Acta Ophthalmol; 2018 Nov; 96(7):e893-e894. PubMed ID: 29030918
    [No Abstract]   [Full Text] [Related]  

  • 11. DEXAMETHASONE IMPLANT REMOVAL FROM ANTERIOR CHAMBER: SURGICAL TECHNIQUE.
    Ruiz-Casas D; Gros-Otero J; Casado A
    Retin Cases Brief Rep; 2016; 10(4):313-5. PubMed ID: 27124797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleral fixation of dexamethasone intravitreal implant (OZURDEX®) in a case of angle-supported lens implantation.
    Mateo C; Alkabes M; Burés-Jelstrup A
    Int Ophthalmol; 2014 Jun; 34(3):661-5. PubMed ID: 23928945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OFFICE MANAGEMENT OF OZURDEX IMPLANT DISLOCATION INTO THE ANTERIOR CHAMBER.
    Ahuja AS; Jaraki JA; Halperin LS
    Retin Cases Brief Rep; 2023 Mar; 17(2):170-172. PubMed ID: 33731604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete scleral penetration of dexamethasone (Ozurdex) intravitreal implant.
    Sherman T; Raman V
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of a migrated dexamethasone implant (Ozurdex) from the anterior chamber using an intravenous cannula.
    Ku JY; Mercieca K; Yau K
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34244184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®).
    Pardo-López D; Francés-Muñoz E; Gallego-Pinazo R; Díaz-Llopis M
    Graefes Arch Clin Exp Ophthalmol; 2012 Nov; 250(11):1703-4. PubMed ID: 21861084
    [No Abstract]   [Full Text] [Related]  

  • 17. Corneal toxicity after Ozurdex(®) migration into anterior chamber.
    Bernal L; Estévez B
    Arch Soc Esp Oftalmol; 2016 Jun; 91(6):292-4. PubMed ID: 26922138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.
    Stepanov A; Codenotti M; Ramoni A; Prati M; Jiraskova N; Rozsival P; Bandello F
    Eur J Ophthalmol; 2016 Apr; 26(3):e52-4. PubMed ID: 26615950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pupilloplasty to prevent dexamethasone intravitreal implant migration to anterior chamber.
    Medeiros Pinto J; Marques-Neves C
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28433977
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema.
    Turaka K; Kwong HM; De Souza S
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):196-7. PubMed ID: 23402344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.